Article
KIT D816V is dimerization-independent and activates downstream pathways frequently perturbed in mastocytosis.
British journal of haematology - 1 Sept 2023
Rajan Vinothkumar, Prykhozhij Sergey V, Pandey Aditya, Cohen Alejandro M, Rainey Jan K, Berman Jason N
Abstract excerpt
KIT, a type III tyrosine kinase receptor, plays a crucial role in haematopoietic development. The KIT receptor forms a dimer after ligand binding; this activates tyrosine kinase activity leading to downstream signal transduction. The D816V KIT mutation is extensively implicated in haematological malignancies, including mastocytosis and leukaemia. KIT D816V is constitutively active, but the molecular nuances that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
